A new dosing regimen for Kisunla, to help lower the risk of certain side effects, has been approved by the U.S. Food and Drug ...

The Alzheimer's Association is urging patients, caregivers, and advocates to "take action now" and support legislation this awareness month.

Alzheimer’s Association urging ‘action now’ for awareness month June is Alzheimer’s and Brain Awareness Month, and the Alzheimer’s Association is urging patients, caregivers, and supporters to “take ...

Moderate stage Alzheimer's is the second and longest stage of this brain disease, likely marked by increased forgetfulness, confusion, and trouble speaking.

A dual vaccine targeting both amyloid plaques and tangled fibers made up of tau may have potential to treat and prevent Alzheimer’s disease.

The small snacks available in the U.S. and U.K. encourage people with Alzheimer's and dementia to increase their water intake.

Experts in Alzheimer’s and dementia care explain the challenges of getting an early and accurate diagnosis and what can be done to solve it.

In early-stage Alzheimer's, changes in abilities or behavior may be minor and only noticeable to family and close friends. Some symptoms typify this stage.

Consider the following before gently correcting your loved one: The present stage of dementia and your loved one’s ability to process information. Is the behavior connected to dementia, or was it ...

Nearly half the Alzheimer's disease patients treated with TrueBinding's investigational therapy TB006 showed cognitive improvement signs.

Blazing through a magazine or newspaper is an activity most of us take for granted. However, someone with cognitive impairment may have difficulty devouring content. Deciphering small print and ...

In a significant decision, the FDA approved Adulhelm (aducanumab) as a first targeted Alzheimer's treatment, and first new therapy since 2003.